Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas
Stopped Slow/poor enrollment
Conditions
- Adenocarcinoma of the Pancreas
Interventions
- DRUG: Durvalumab
- RADIATION: Radiation Therapy
Sponsor
Baptist Health South Florida
Collaborators